Amneal Pharmaceuticals, Inc. Human Resources Contracts & Agreements
35 Contracts & Agreements
- Bonus & Incentive Agreements (6 contracts)
- Compensation Agreements (6)
- Employment Agreements (15)
- Separation Agreements (6)
- Severance Agreements (2)
- Amneal Pharmaceuticals, Inc. 2018 Incentive Award Plan, as amended and restated (Filed With SEC on August 8, 2023)
- Modification No. 2 to Employment Agreement, dated February 21, 2023, by and among Amneal Pharmaceuticals, Inc. and Andrew Boyer (Filed With SEC on May 9, 2023)
- Modification No. 1 to Employment Agreement, dated February 21, 2023, by and among Amneal Pharmaceuticals, Inc. and Nikita Shah (Filed With SEC on May 9, 2023)
- Modification No. 2 to Employment Agreement, dated February 21, 2023, by and among Amneal Pharmaceuticals, Inc. and Anastasios Konidaris (Filed With SEC on May 9, 2023)
- Employment Agreement dated September 1, 2022, by and between Amneal Pharmaceuticals, Inc. and Gustavo Pesquin (Filed With SEC on September 6, 2022)
- Amneal Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended on August 4, 2022 (Filed With SEC on August 8, 2022)
- Amneal Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended and restated on May 5, 2021 (Filed With SEC on August 9, 2021)
- Employment Agreement by and among Amneal Pharmaceuticals, Inc. and Nikita Shah, dated as of July 29, 2020 (Filed With SEC on May 7, 2021)
- Employment Agreement by and among Amneal Pharmaceuticals, Inc. and Joseph Todisco, dated as of July 29, 2020 (Filed With SEC on May 7, 2021)
- Amneal Pharmaceuticals, Inc. Non- Employee Director Compensation Policy (Filed With SEC on March 1, 2021)
- Form of Amneal Pharmaceuticals, Inc. 2018 Incentive Award Plan Performance Restricted Stock Unit Grant Notice and Performance Restricted Stock Unit Agreement (2020) (Filed With SEC on March 1, 2021)
- Modification No. 1 to Employment Agreement, effective as of August 1, 2020, by and among Amneal Pharmaceuticals LLC, Amneal Holdings, LLC and Andrew Boyer (Filed With SEC on November 6, 2020)
- Amneal Pharmaceuticals LLC Severance Plan and Summary Plan Description (Filed With SEC on August 6, 2020)
- Form of Amneal Pharmaceuticals, Inc. 2018 Incentive Plan Performance Restricted Stock Unit Grant Notice and Performance Restricted Stock Unit Agreement (Filed With SEC on May 11, 2020)
- First Amendment to Separation Agreement between David Buchen, Amneal Pharmaceuticals, Inc. and Amneal Pharmaceuticals LLC, dated as of November 4, 2019 (Filed With SEC on May 11, 2020)
- Separation Agreement between David Buchen, Amneal Pharmaceuticals, Inc. and Amneal Pharmaceuticals LLC, dated as of August 2, 2019 (Filed With SEC on May 11, 2020)
- Employment Agreement by and among Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals, Inc. and David Buchen, dated as of December 28, 2018 (Filed With SEC on May 11, 2020)
- Separation Agreement between Todd Branning, Amneal Pharmaceuticals, Inc. and Amneal Pharmaceuticals LLC, dated as of March 11, 2020 (Filed With SEC on May 11, 2020)
- Employment Agreement, dated March 11, 2020, by and among Amneal Pharmaceuticals LLC, the Company and Anastasios (Tasos) G. Konidaris (Filed With SEC on March 12, 2020)
- Amneal Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (Filed With SEC on March 2, 2020)
- Separation Agreement between Robert Stewart, Amneal Pharmaceuticals, Inc. and Amneal Pharmaceuticals LLC, dated as of August 2, 2019 (Filed With SEC on August 5, 2019)
- Amneal Pharmaceuticals LLC 2019 Severance Plan (Filed With SEC on May 9, 2019)
- Separation Agreement, dated February 28, 2019, by and between Bryan Reasons and Amneal Pharmaceuticals, Inc (Filed With SEC on March 1, 2019)
- Separation Agreement, dated February 5, 2019, by and between Sheldon Hirt and Amneal Pharmaceuticals, Inc (Filed With SEC on March 1, 2019)
- Form of Amneal Pharmaceuticals, Inc. 2018 Incentive Award Plan Performance Restricted Stock Unit Grant Notice and Performance Restricted Stock Unit Agreement (Filed With SEC on March 1, 2019)
- Employment Agreement, dated January 21, 2019, by and among the Company, Amneal Pharmaceuticals LLC, and Todd P. Branning (Filed With SEC on January 24, 2019)
- Amneal Pharmaceuticals, Inc. 2018 Incentive Award Plan (Filed With SEC on August 9, 2018)
- Amendment to Impax Laboratories, Inc. Executive Non-Qualified Deferred Compensation Plan, effective as of January 1, 2009 (Filed With SEC on April 13, 2018)
- Impax Laboratories, Inc. Executive Non-Qualified Deferred Compensation Plan, amended and restated effective January 1, 2008 (Filed With SEC on April 13, 2018)
- Amendment to Employment Agreement, dated April 1, 2014, by and between Impax Laboratories, Inc. and Bryan M. Reasons (Filed With SEC on April 13, 2018)
- Employment Agreement, dated December 12, 2012, by and among Impax Laboratories, Inc. and Bryan M. Reasons (Filed With SEC on April 13, 2018)
- Employment Agreement, dated January 24, 2018, by and among Amneal Pharmaceuticals LLC, Amneal Holdings, LLC and Andrew Boyer (Filed With SEC on April 13, 2018)
- Employment Agreement, dated March 24, 2017, by and between Impax Laboratories, Inc. and Paul M. Bisaro (Filed With SEC on April 13, 2018)
- Employment Agreement, dated December 16, 2017, by and among Amneal Pharmaceuticals LLC, Atlas Holdings, Inc. and Robert A. Stewart (Filed With SEC on April 13, 2018)
- Form of Atlas Holdings, Inc. 2018 Incentive Award Plan (Filed With SEC on April 13, 2018)
